David J. Wright

机构：University of Liverpool, Emory University, Boston Scientific (United States), Liverpool Heart and Chest Hospital · ORCID：0000-0002-5783-6648

发表论文 81 篇 · 总被引 3831 次 · h-index 26

代表论文

• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (2023 · New England Journal of Medicine · 被引 435)
• Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial (2022 · European Heart Journal · 被引 95)
• Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis (2022 · Journal of Medical Internet Research · 被引 63)
• Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial (2025 · The Lancet Neurology · 被引 50)
• Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: An Analysis of All Appropriate Therapy in the PRAETORIAN trial (2021 · UCL Discovery (University College London) · 被引 46)
• Pharmacology of TRPC Channels and Its Potential in Cardiovascular and Metabolic Medicine (2021 · The Annual Review of Pharmacology and Toxicology · 被引 35)